safety and efficacy of plamotamab in the treatment of non-hodgkin lymphoma subtypes
Published 2 years ago • 152 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
3:02
the safety and efficacy of the syk inhibitor sovleplenib in heavily pre-treated hodgkin lymphoma
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
3:12
an overview of the current treatment landscape of non-hodgkin lymphoma
-
4:09
real-world safety and efficacy of liso-cel in r/r large b-cell lymphoma
-
1:35
update on phase i study of plamotamab in r/r nhl
-
54:43
closed caption version - wm basics diagnostics, understanding lab tests, symptoms
-
1:00:50
hodgkin's lymphoma
-
17:14
non-hodgkin lymphoma | how i got through diagnosis & treatment | paige's story | the patient story
-
1:12
the safety and efficacy of mb-106 for the treatment of waldenström’s macroglobulinemia
-
1:25
the current approach to managing patients with prefibrotic pmf
-
1:19
safety and efficacy of mb-106 for the treatment of r/r fl
-
1:22
safety and efficacy of golcadomide (cc-99282) in the treatment of r/r nhl
-
5:04
efficacy and safety of m-pola for r/r b-cell nhl
-
1:14
are biomarkers the future in non-hodgkin lymphoma?
-
0:59
cami-t in r/r chl: analysis of clinical determinants of safety and efficacy
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
1:17
the importance of risk-adapted therapies in hodgkin lymphoma
-
0:44
risk of transformation by frontline management in fl and mzl: a us population-based analysis
-
1:27
diagnosis and risk stratification in hodgkin lymphoma: updates and novel approaches
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
2:41
safety and efficacy of actaly-cel™ in r/r pediatric b-all